TITLE

IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular Morphology

AUTHOR(S)
Popov, Sergey; Jury, Alexa; Laxton, Ross; Doey, Lawrence; Kandasamy, Naga; Al-Sarraj, Safa; Jürgensmeier, Juliane M.; Jones, Chris
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Glioblastoma is a highly aggressive tumour with marked heterogeneity at the morphological level in both the tumour cells and the associated highly prominent vasculature. As we begin to develop an increased biological insight into the underlying processes driving the disease, fewer attempts have thus far been made to understand these phenotypic differences. We sought to address this by carefully assessing the morphological characteristics of both the tumour cells and the associated vasculature, relating these observations to the IDH1/MGMT status, with a particular focus on the early onset population of young adults who develop primary glioblastoma. 276 primary glioblastoma specimens were classified into their predominant cell morphological type (fibrillary, gemistocytic, giant cell, small cell, oligodendroglial, sarcomatous), and assessed for specific tumour (cellularity, necrosis, palisades) and vascular features (glomeruloid structures, arcades, pericyte proliferation). IDH1 positive glioblastomas were associated with a younger age at diagnosis, better clinical outcome, prominent oligodendroglial and small cell tumour cell morphology, pallisading necrosis and glomeruloid vascular proliferation in the absence of arcade-like structures. These features widen the phenotype of IDH1 mutation-positive primary glioblastoma in young adults and provide correlative evidence for a functional role of mutant IDH1 in the differential nature of neo-angiogenesis in different subtypes of glioblastoma.
ACCESSION #
87624503

 

Related Articles

  • Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. Kwon, So Mee; Kang, Shin-Hyuk; Park, Chul-Kee; Jung, Shin; Park, Eun Sung; Lee, Ju-Seog; Kim, Se-Hyuk; Woo, Hyun Goo // PLoS ONE;10/14/2015, Vol. 10 Issue 10, p1 

    Previously, transcriptomic profiling studies have shown distinct molecular subtypes of glioblastomas. It has also been suggested that the recurrence of glioblastomas could be achieved by transcriptomic reprograming of tumors, however, their characteristics are not yet fully understood. Here, to...

  • Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy. Hattingen, Elke; Bähr, Oliver; Rieger, Johannes; Blasel, Stella; Steinbach, Joachim; Pilatus, Ulrich // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Purpose: Metabolic changes upon antiangiogenic therapy of recurrent glioblastomas (rGBMs) may provide new biomarkers for treatment efficacy. Since in vitro models showed that phospholipid membrane metabolism provides specific information on tumor growth we employed in-vivo MR-spectroscopic...

  • The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment. Kast, Richard E.; Scheuerle, Angelika; Wirtz, Christian R.; Karpel-Massler, Georg; Halatsch, Marc-Eric // Anti-Cancer Agents in Medicinal Chemistry;2011, Vol. 11 Issue 8, p756 

    Data from past research is presented showing that neutrophils are active participants in new vessel formation in normal physiology, in proliferating human endometrium, in non-cancer pathologies as in the pannus of rheumatoid arthritis, and in various cancers, among them glioblastoma. These data...

  • Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma. Zhang, Y; Kim, J; Mueller, A C; Dey, B; Yang, Y; Lee, D-h; Hachmann, J; Finderle, S; Park, D M; Christensen, J; Schiff, D; Purow, B; Dutta, A; Abounader, R // Cell Death & Differentiation;May2014, Vol. 21 Issue 5, p720 

    Receptor tyrosine kinases (RTKs) are co-deregulated in a majority of glioblastoma (GBM), the most common and most deadly brain tumor. We show that the RTKs MET, EGFR, and PDGFR regulate microRNA-134 (miR-134) in GBM. We find that miR-134 is downregulated in human tumors and cancer stem cells and...

  • A Multilayer Grow-or-Go Model for GBM: Effects of Invasive Cells and Anti-Angiogenesis on Growth. Saut, Olivier; Lagaert, Jean-Baptiste; Colin, Thierry; Fathallah-Shaykh, Hassan // Bulletin of Mathematical Biology;Sep2014, Vol. 76 Issue 9, p2306 

    The recent use of anti-angiogenesis (AA) drugs for the treatment of glioblastoma multiforme (GBM) has uncovered unusual tumor responses. Here, we derive a new mathematical model that takes into account the ability of proliferative cells to become invasive under hypoxic conditions; model...

  • FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. Lee, Yeri; Kim, Kang Ho; Kim, Dong Geon; Cho, Hee Jin; Kim, Yeonghwan; Rheey, Jinguen; Shin, Kayoung; Seo, Yun Jee; Choi, Yeon-Sook; Lee, Jung-Il; Lee, Jeongwu; Joo, Kyeung Min; Nam, Do-Hyun // PLoS ONE;10/7/2015, Vol. 10 Issue 10, p1 

    Glioblastoma (GBM) is the most aggressive and most lethal brain tumor. As current standard therapy consisting of surgery and chemo-irradiation provides limited benefit for GBM patients, novel therapeutic options are urgently required. Forkhead box M1 (FoxM1) transcription factor is an oncogenic...

  • K604, a specific acyl-CoA:cholesterol acyltransferase 1 inhibitor, suppresses proliferation of U251-MG glioblastoma cells. TAKUJI OHMOTO; KAZUCHIKA NISHITSUJI; NOBUYUKI YOSHITANI; MAKOTO MIZUGUCHI; YUTO YANAGISAWA; HIROYUKI SAITO; NAOMI SAKASHITA // Molecular Medicine Reports;2015, Vol. 12 Issue 4, p6037 

    Glioblastoma is the most aggressive type of brain tumor and has a poor prognosis. Increased levels of cholesteryl ester and simultaneous expression of acyl-CoA:cholesterol acyltransferase 1 (ACAT1) in tumor cells indicated that cholesterol esterification is critical to tumor growth. The present...

  • Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells. Lin Zhang; Gan Wang; Shiwen Chen; Jun Ding; Shiming Ju; Heli Cao; Hengli Tian // World Journal of Surgical Oncology;10/19/2016, Vol. 14, p1 

    Background: Glioblastoma (GBM) is the most malignant nervous system tumor with an almost 100% recurrence rate. Thymopoietin (TMPO) has been demonstrated to be upregulated in various tumors, including lung cancer, breast cancer, and so on, but its role in GBM has not been reported. This study was...

  • Secondary gliosarcoma after the treatment of primary glioblastoma multiforme. Andaloussi-Saghir, Khalid; Oukabli, Mohamed; Marjany, Mohammed El; Sifat, Hassan; Hadadi, Khalid; Mansouri, Hamid // North American Journal of Medical Sciences;Nov2011, Vol. 3 Issue 11, p527 

    Context: Gliosarcoma is a rare variant of glioblastoma multiforme containing distinct gliomatous and sarcomatous components. Gliosarcoma comprise 1.8-8% of glioblastoma multiforme and are clinically similar to them, affecting adults in the fourth and sixth decades of life, with a higher...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics